GW-501516 GlaxoSmithKline/Ligand.

GW-501516 GlaxoSmithKline/Ligand.

Item
http://www.wikidata.org/entity/Q34515353
Alternative splicing of human peroxisome proliferator-activated receptor delta (PPAR delta): effects on translation efficiency and trans-activation ability.Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.PPARgamma and PPARdelta as Modulators of Neoplasia and Cell FatePPAR Ligands as Potential Modifiers of Breast Carcinoma Outcomes.PPARδ induces estrogen receptor-positive mammary neoplasia through an inflammatory and metabolic phenotype linked to mTOR activation.Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.Ligand-activated peroxisome proliferator-activated receptor β/δ modulates human endometrial cancer cell survival.PPARs as determinants of the estrogen receptor lineage: use of synthetic lethality for the treatment of estrogen receptor-negative breast cancer.
P2860

GW-501516 GlaxoSmithKline/Ligand.

Item
http://www.wikidata.org/entity/Q34515353
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
GW-501516 GlaxoSmithKline/Ligand.
@ast
GW-501516 GlaxoSmithKline/Ligand.
@en
GW-501516 GlaxoSmithKline/Ligand.
@nl
type
label
GW-501516 GlaxoSmithKline/Ligand.
@ast
GW-501516 GlaxoSmithKline/Ligand.
@en
GW-501516 GlaxoSmithKline/Ligand.
@nl
prefLabel
GW-501516 GlaxoSmithKline/Ligand.
@ast
GW-501516 GlaxoSmithKline/Ligand.
@en
GW-501516 GlaxoSmithKline/Ligand.
@nl
P1433
P1476
P2093
P304
P31
P433
P478
P577
P698
P921
P1433
P1476
GW-501516 GlaxoSmithKline/Ligand
@en
P2093
P304
P31
P433
P478
P577
P698
P921